Chief executive of Array BioPharma resigns
Chairman Kyle Lefkoff will lead effort to replace Robert Conway
Lefkoff said he will work with the Array management team to ensure a smooth transition and continued advancement of the company’s multiple clinical programmes in cancer and inflammation and supporting our many partnered programmes.